Cytomegalovirus Infection and Disease in Lung Transplant Recipients

被引：0
作者：
Lynch, B. L. [1 ]
Ging, P. [2 ]
Ronayne, A. [3 ]
De Gascun, C. [3 ]
Kleinerova, J. [4 ]
Egan, J. J. [4 ]
Hannan, M. M. [1 ]
机构：
[1] Mater Misericordiae Univ Hosp, Clin Microbiol, Dublin 7, Ireland
[2] Mater Misericordiae Univ Hosp, Dept Pharm, Dublin 7, Ireland
[3] Natl Virus Reference Lab, Dublin 4, Ireland
[4] Mater Misericordiae Univ Hosp, Dept Resp & Transplant, Dublin 7, Ireland
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2019年 / 38卷 / 04期
关键词：
D O I：
10.1016/j.healun.2019.01.787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
777
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [21] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
    Fellay, J
    Venetz, JP
    Aubert, JD
    Seydoux, C
    Pascual, M
    Meylan, PRA
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 949 - 951
  • [22] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir
    Fellay, J
    Venetz, JP
    Pascual, M
    Aubert, JD
    Seydoux, C
    Meylan, PR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (07) : 1781 - 1782
  • [23] Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
    Ljungman, P
    Deliliers, GL
    Platzbecker, U
    Matthes-Martín, S
    Bacigalupo, A
    Einsele, H
    Ullmann, J
    Musso, M
    Trenschel, R
    Ribaud, P
    Bornhäuser, M
    Cesaro, S
    Crooks, B
    Dekker, A
    Gratecos, N
    Klingebiel, T
    Tagliaferri, E
    Ullmann, AJ
    Wacker, P
    Cordonnier, C
    BLOOD, 2001, 97 (02) : 388 - 392
  • [24] PROPHYLACTIC GANCICLOVIR PREVENTS CYTOMEGALOVIRUS DISEASE IN LUNG-TRANSPLANT RECIPIENTS
    FOX, J
    EDIN, C
    DOSLAND, E
    PETTY, M
    BOLMAN, RM
    HERTZ, M
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A600 - A600
  • [25] ASSOCIATION OF CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS WITH CYTOMEGALOVIRUS INFECTION
    MCDONALD, K
    RECTOR, TS
    BRAUNLIN, EA
    KUBO, SH
    OLIVARI, MT
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (05) : 359 - 362
  • [26] Preemptive treatment for the prevention of cytomegalovirus disease - In lung and heart transplant recipients
    Egan, JJ
    Lomax, J
    Barber, L
    Lok, SS
    Martyszczuk, R
    Yonan, N
    Fox, A
    Deiraniya, AK
    Turner, AJ
    Woodcock, AA
    TRANSPLANTATION, 1998, 65 (05) : 747 - 752
  • [27] A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients
    Humar, A
    Siegal, D
    Moussa, G
    Kumar, D
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (07) : 1154 - 1157
  • [28] Management Strategies for Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
    Razonable, Raymund R.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2013, 27 (02) : 317 - +
  • [29] Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients.
    Borges, L. F.
    Sparkman, T.
    Gutierrez, K.
    Banbury, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 988 - 988
  • [30] Management of cytomegalovirus infection in lung transplant recipients: Evidence-based recommendations
    Zamora, MR
    Davis, RD
    Leonard, C
    TRANSPLANTATION, 2005, 80 (02) : 157 - 163
12345